These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase. Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors. Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214 [TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives. Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives. Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769 [TBL] [Abstract][Full Text] [Related]
10. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity. Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors. Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Cirilli R; La Torre F; Alcaro S; Ortuso F; Langer T Curr Med Chem; 2006; 13(12):1411-28. PubMed ID: 16719786 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase. Maccioni E; Alcaro S; Orallo F; Cardia MC; Distinto S; Costa G; Yanez M; Sanna ML; Vigo S; Meleddu R; Secci D Eur J Med Chem; 2010 Oct; 45(10):4490-8. PubMed ID: 20702005 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of 1,3,5-triphenyl-4,5-dihydro-(1H)-pyrazole derivatives on activity of amine oxidases. Manna F; Chimenti F; Bolasco A; Bizzarri B; Befani O; Pietrangeli P; Mondovi B; Turini P J Enzyme Inhib; 1998 Jun; 13(3):207-16. PubMed ID: 9629538 [TBL] [Abstract][Full Text] [Related]
14. A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Gökhan-Kelekçi N; Yabanoğlu S; Küpeli E; Salgin U; Ozgen O; Uçar G; Yeşilada E; Kendi E; Yeşilada A; Bilgin AA Bioorg Med Chem; 2007 Sep; 15(17):5775-86. PubMed ID: 17611112 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors. Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Yáñez M; Vitali A; Ortuso F; Alcaro S Bioorg Med Chem Lett; 2010 Nov; 20(22):6479-82. PubMed ID: 20934874 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies. Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657 [TBL] [Abstract][Full Text] [Related]
18. 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors. Gökhan N; Yeşilada A; Uçar G; Erol K; Bilgin AA Arch Pharm (Weinheim); 2003 Aug; 336(8):362-71. PubMed ID: 14502756 [TBL] [Abstract][Full Text] [Related]
19. 3-Aryl-1-phenyl-1H-pyrazole derivatives as new multitarget directed ligands for the treatment of Alzheimer's disease, with acetylcholinesterase and monoamine oxidase inhibitory properties. Kumar A; Jain S; Parle M; Jain N; Kumar P EXCLI J; 2013; 12():1030-42. PubMed ID: 27298613 [TBL] [Abstract][Full Text] [Related]
20. Molecular Docking Studies of Some Novel Antidepressant 5-Substituted Phenyl-3-(Thiophen-2-yl)-4, 5-Dihydro-1h-Pyrazole-1-Carboxamides Against Monoamine Oxidase Isoforms. Mathew B; Suresh J; Anbazhagan S; Dev S Cent Nerv Syst Agents Med Chem; 2016; 16(2):75-80. PubMed ID: 25687583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]